| |
| |
|
| Insider
Information: |
Hurwitz Edward |
| Relationship: |
Director, 10% Owner |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
1,518,497 |
|
|
Indirect Shares
|
2,213,245 |
|
|
| Direct
Value |
$1,127,398 |
|
|
|
Indirect Value
|
$27,414,621 |
|
|
| Total
Shares |
3,731,742 |
|
|
| Total
Value |
$28,542,019 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Viracta Therapeutics Ord Shs |
VIRX |
Director |
|
0 |
2010-06-30 |
381,683 |
Premium* |
|
|
Molecular Templates, Inc. |
MTEM |
Former 10% owner |
2009-10-05 |
1,439,921 |
2009-10-05 |
35,485 |
Premium* |
|
|
Aegerion Pharmaceuticals, Inc. |
AEGR |
10% Owner |
2010-10-27 |
60,502 |
2010-10-27 |
0 |
Premium* |
|
|
Macrogenics Inc |
MGNX |
Director |
2015-05-11 |
18,074 |
2014-02-18 |
1,704,996 |
Premium* |
|
|
Applied Genetic Technologies Corp |
AGTC |
Director |
2022-11-30 |
0 |
2022-11-30 |
0 |
Premium* |
|
|
Dyne Therapeutics, Inc. |
DYN |
Director, 10% Owner |
2020-09-21 |
0 |
2020-09-21 |
91,081 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGTC |
Applied Genetic Technolog... |
Director |
– • – |
2022-11-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,800) |
0 |
0 |
- |
|
| AGTC |
Applied Genetic Technolog... |
Director |
– • – |
2022-11-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(25,672) |
0 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
Director |
– • • |
2020-09-21 |
4 |
A |
$0.00 |
$0 |
I/I |
4,951,303 |
91,081 |
0 |
- |
|
| AGTC |
Applied Genetic Technolog... |
Director |
– • – |
2018-05-24 |
4 |
A |
$0.00 |
$0 |
I/I |
25,672 |
27,472 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Director |
– • – |
2015-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
18,074 |
18,074 |
0 |
- |
|
| AGTC |
Applied Genetic Technolog... |
Director |
– • – |
2014-11-17 |
4 |
A |
$0.00 |
$0 |
I/I |
1,800 |
1,800 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Director |
– • – |
2014-02-18 |
4 |
S |
$36.50 |
$11,260,725 |
I/I |
(308,513) |
1,704,996 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Director |
– • – |
2013-10-16 |
4 |
OE |
$0.00 |
$0 |
I/I |
15,314 |
2,013,509 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Director |
– • – |
2013-10-16 |
4 |
A |
$0.00 |
$0 |
I/I |
1,998,195 |
1,998,195 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
10% Owner |
– – • |
2010-10-27 |
4 |
B |
$9.50 |
$2,999,996 |
D/D |
315,789 |
60,502 |
2.45 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
10% Owner |
– – • |
2010-10-27 |
4 |
A |
$0.00 |
$5,808,756 |
D/D |
2,364,762 |
53,374 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2010-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
4,997,470 |
381,683 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • – |
2010-06-30 |
4 |
A |
$0.28 |
$3,275,862 |
I/I |
11,912,224 |
268,883 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • • |
2009-12-14 |
4 |
S |
$2.01 |
$4,485,913 |
I/I |
(2,232,464) |
0 |
0 |
- |
|
| MTEM |
Molecular Templates, Inc. |
Former 10% owner |
– – – |
2009-10-05 |
4 |
B |
$1.91 |
$42,043 |
I/I |
22,012 |
35,485 |
0.01 |
- |
|
| MTEM |
Molecular Templates, Inc. |
Former 10% owner |
– – – |
2009-10-05 |
4 |
B |
$1.91 |
$457,957 |
D/D |
239,768 |
1,439,921 |
2.44 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
Director |
– • • |
2009-04-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,232,464 |
|
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
